Lantern has teamed up with AccessHope to broaden access to its AI-powered cancer care navigation platform. The collaboration combines Lantern’s digital tools for personalized patient support with AccessHope’s oncology expertise, enabling more cancer patients to receive guided navigation, second opinions, treatment insights, and emotional support throughout their journey.

Glimpse:

Through the partnership, AccessHope’s network of academic oncologists will integrate with Lantern’s platform to deliver virtual second opinions, clinical trial matching, symptom management guidance, and care coordination. Lantern’s AI-driven app uses patient data to offer tailored recommendations, reduce treatment delays, and improve adherence. The alliance aims to make high-quality cancer navigation more accessible, especially for patients in underserved or rural areas.

Lantern, a digital health company specializing in cancer care navigation, has announced a strategic partnership with AccessHope, a nonprofit oncology services provider affiliated with City of Hope. The collaboration expands Lantern’s platform by incorporating AccessHope’s deep clinical expertise, allowing more patients to benefit from expert-guided care without needing to travel to major cancer centers.

Lantern’s platform uses AI to analyze patient records, treatment history, and preferences, then delivers personalized support including: Treatment pathway education and shared decision-making tools Virtual second opinions from board-certified oncologists Clinical trial matching and eligibility screening Symptom tracking with proactive alerts to care teams Emotional and financial navigation resources

AccessHope brings its network of subspecialty oncologists from City of Hope and other leading institutions, providing high-level input for complex cases. Together, the partners aim to reduce care fragmentation, minimize delays in treatment initiation, improve clinical trial access, and enhance overall patient experience particularly for those facing barriers to specialized care.

The partnership reflects the growing emphasis on patient-centered navigation in oncology, where coordinated support has been shown to improve adherence, satisfaction, and outcomes. Lantern and AccessHope plan to roll out joint offerings initially in the US, with potential future expansion to support global cancer patients.

This alliance positions Lantern as a more comprehensive solution in the evolving landscape of digital oncology support services.

“Cancer care should never feel like navigating alone. By combining our platform with AccessHope’s oncology expertise, we’re giving more patients the expert guidance they deserve.”